Tandem Mobi Integrates with Dexcom G7 CGM, Expanding Choice for Diabetes Management
Tandem Mobi insulin pump with Control-IQ technology is now compatible with both the Dexcom G7 and Dexcom G6 GM systems.
Stay updated with breaking news from Glycemic Control. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tandem Mobi insulin pump with Control-IQ technology is now compatible with both the Dexcom G7 and Dexcom G6 GM systems.
Sanofi India has launched its diabetes drug Soliqua in India, a once-daily injectable combination drug containing insulin and GLP-1 receptor agonist lixisenatide. The medication is available at a therapy cost of Rs 1,850 per pen and is indicated for adults with obesity and type 2 diabetes to improve glycemic control.
Discover how a low-fat vegan diet transforms insulin needs and heart health for Type 1 diabetes patients.
Discover the latest clinical trial results the effectiveness of bariatric surgery for Type 2 diabetes patients and lifestyle and medical changes.
/PRNewswire/ -- It's a scientific fact. The human body requires nutrient-rich foods for optimal health and wellness. The vitamins and minerals in...